May 22, 2020
Teva has new Ajovya nalyses and latest Copaxone Data
Teva will present new data on Ajovy and on the long-term safety and efficacy of Copaxone at at the 6th Congress of the European Academy of Neurology
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Copaxone
April 1, 2019
Teva’s COPAXONE® 40mg – Favorable Response from European Patent Office
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that a three-member panel of the European Patent Office’s…
December 23, 2016
Israeli’s largest drugmaker Teva agrees to pay U.S. government $519M over foreign bribery charges
Israeil’s largest drugmaker Teva Pharmaceuticals Industries has settled with the United States government over international bribery of government officials in…
September 29, 2015
Teva’s COPAXONE approved in Japan for the Prevention of Relapse of Multiple Sclerosis
Teva Pharmaceutical Industries Ltd. announced on Monday that its glatiramer acetate injection was approved by the Japanese Ministry of Health, Labour and Welfare (MHLW)…